![Dawn Pinchasik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dawn Pinchasik currently works at TScan Therapeutics, Inc., as Vice President-Clinical Development from 2024.
Dr. Pinchasik received her graduate degree from the University of Cincinnati (Ohio) and doctorate degree from Drexel University College of Medicine.
| Bedrijven | Functie | Begin |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 06-02-2024 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
University of Cincinnati (Ohio)
 University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
 Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
